Rapport Therapeutics, Inc. (RAPP)
32.24
-0.14
(-0.43%)
USD |
NASDAQ |
Apr 07, 13:00
Rapport Therapeutics Total Liabilities (Quarterly) : 27.78M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| EyePoint Plc | 57.88M |
| Praxis Precision Medicines, Inc. | 59.79M |
| Bridgebio Oncology Therapeutics, Inc. | 37.98M |
| Olema Pharmaceuticals, Inc. | 198.76M |
| Arcellx, Inc. | 201.64M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 512.43M |
| Shareholders Equity (Quarterly) | 484.65M |
| Debt to Equity Ratio | 0.0237 |
| Current Ratio | 26.17 |
| Net Debt Paydown Yield | -0.14% |